Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information
Gespeichert in:
| Veröffentlicht in: | Yale journal of health policy, law, and ethics law, and ethics, 2010, Vol.10 (2), p.299-356 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 356 |
|---|---|
| container_issue | 2 |
| container_start_page | 299 |
| container_title | Yale journal of health policy, law, and ethics |
| container_volume | 10 |
| creator | Osborn, John E |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_748995710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748995710</sourcerecordid><originalsourceid>FETCH-LOGICAL-p125t-3d0be36d259ec27620a4a7cbc8825848731289e978fa6f3bde7c9faaaaf688953</originalsourceid><addsrcrecordid>eNo1kEtrwzAQhHVoadK0f6Ho1pNBlixLOpUQ-ggEemnPRpZXiYosuZJcyL-v6WMuszAfy-5coHXNGa8YZ3SFrnP-IISRmrVXaEVJK-uGyTUKOx3wHhfwHp_jjMsJcElzOT3gLTZxnHTSxX0BniDlCczPHANOcJz9koQjjtZWXvfgcTYOQnHWGazDgEcYnNEeu2BjGhc4hht0abXPcPvnG_T-9Pi2e6kOr8_73fZQTTXlpWID6YG1A-UKDBUtJbrRwvRGSsplIwWrqVSghLS6tawfQBhl9SLbSqk426D7371Tip8z5NKNLpvlSR0gzrkTjVSKi5os5N0fOffLwd2U3KjTufuviH0Dl59i8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748995710</pqid></control><display><type>article</type><title>Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information</title><source>MEDLINE</source><source>HeinOnline Law Journal Library</source><creator>Osborn, John E</creator><creatorcontrib>Osborn, John E</creatorcontrib><identifier>ISSN: 1535-3532</identifier><identifier>PMID: 20681438</identifier><language>eng</language><publisher>United States</publisher><subject>Adenine - analogs & derivatives ; Adenine - therapeutic use ; Angiogenesis Inhibitors - therapeutic use ; Anti-HIV Agents - therapeutic use ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized ; Benzhydryl Compounds - therapeutic use ; Bevacizumab ; Botulinum Toxins, Type A - therapeutic use ; Central Nervous System Stimulants - therapeutic use ; Drug Industry - ethics ; Drug Industry - legislation & jurisprudence ; Ethics, Medical ; Humans ; Legislation, Drug - ethics ; Legislation, Drug - trends ; Neuromuscular Agents - therapeutic use ; Off-Label Use - ethics ; Off-Label Use - legislation & jurisprudence ; Organophosphonates - therapeutic use ; Policy Making ; Public Policy - legislation & jurisprudence ; Public Policy - trends ; Ranibizumab ; Tenofovir ; Treatment Outcome ; Truth Disclosure ; United Kingdom ; United States ; United States Food and Drug Administration</subject><ispartof>Yale journal of health policy, law, and ethics, 2010, Vol.10 (2), p.299-356</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20681438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Osborn, John E</creatorcontrib><title>Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information</title><title>Yale journal of health policy, law, and ethics</title><addtitle>Yale J Health Policy Law Ethics</addtitle><subject>Adenine - analogs & derivatives</subject><subject>Adenine - therapeutic use</subject><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Benzhydryl Compounds - therapeutic use</subject><subject>Bevacizumab</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Central Nervous System Stimulants - therapeutic use</subject><subject>Drug Industry - ethics</subject><subject>Drug Industry - legislation & jurisprudence</subject><subject>Ethics, Medical</subject><subject>Humans</subject><subject>Legislation, Drug - ethics</subject><subject>Legislation, Drug - trends</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>Off-Label Use - ethics</subject><subject>Off-Label Use - legislation & jurisprudence</subject><subject>Organophosphonates - therapeutic use</subject><subject>Policy Making</subject><subject>Public Policy - legislation & jurisprudence</subject><subject>Public Policy - trends</subject><subject>Ranibizumab</subject><subject>Tenofovir</subject><subject>Treatment Outcome</subject><subject>Truth Disclosure</subject><subject>United Kingdom</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>1535-3532</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtrwzAQhHVoadK0f6Ho1pNBlixLOpUQ-ggEemnPRpZXiYosuZJcyL-v6WMuszAfy-5coHXNGa8YZ3SFrnP-IISRmrVXaEVJK-uGyTUKOx3wHhfwHp_jjMsJcElzOT3gLTZxnHTSxX0BniDlCczPHANOcJz9koQjjtZWXvfgcTYOQnHWGazDgEcYnNEeu2BjGhc4hht0abXPcPvnG_T-9Pi2e6kOr8_73fZQTTXlpWID6YG1A-UKDBUtJbrRwvRGSsplIwWrqVSghLS6tawfQBhl9SLbSqk426D7371Tip8z5NKNLpvlSR0gzrkTjVSKi5os5N0fOffLwd2U3KjTufuviH0Dl59i8Q</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Osborn, John E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information</title><author>Osborn, John E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p125t-3d0be36d259ec27620a4a7cbc8825848731289e978fa6f3bde7c9faaaaf688953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adenine - analogs & derivatives</topic><topic>Adenine - therapeutic use</topic><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Benzhydryl Compounds - therapeutic use</topic><topic>Bevacizumab</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Central Nervous System Stimulants - therapeutic use</topic><topic>Drug Industry - ethics</topic><topic>Drug Industry - legislation & jurisprudence</topic><topic>Ethics, Medical</topic><topic>Humans</topic><topic>Legislation, Drug - ethics</topic><topic>Legislation, Drug - trends</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>Off-Label Use - ethics</topic><topic>Off-Label Use - legislation & jurisprudence</topic><topic>Organophosphonates - therapeutic use</topic><topic>Policy Making</topic><topic>Public Policy - legislation & jurisprudence</topic><topic>Public Policy - trends</topic><topic>Ranibizumab</topic><topic>Tenofovir</topic><topic>Treatment Outcome</topic><topic>Truth Disclosure</topic><topic>United Kingdom</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Osborn, John E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Yale journal of health policy, law, and ethics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Osborn, John E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information</atitle><jtitle>Yale journal of health policy, law, and ethics</jtitle><addtitle>Yale J Health Policy Law Ethics</addtitle><date>2010</date><risdate>2010</risdate><volume>10</volume><issue>2</issue><spage>299</spage><epage>356</epage><pages>299-356</pages><issn>1535-3532</issn><cop>United States</cop><pmid>20681438</pmid><tpages>58</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1535-3532 |
| ispartof | Yale journal of health policy, law, and ethics, 2010, Vol.10 (2), p.299-356 |
| issn | 1535-3532 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_748995710 |
| source | MEDLINE; HeinOnline Law Journal Library |
| subjects | Adenine - analogs & derivatives Adenine - therapeutic use Angiogenesis Inhibitors - therapeutic use Anti-HIV Agents - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Benzhydryl Compounds - therapeutic use Bevacizumab Botulinum Toxins, Type A - therapeutic use Central Nervous System Stimulants - therapeutic use Drug Industry - ethics Drug Industry - legislation & jurisprudence Ethics, Medical Humans Legislation, Drug - ethics Legislation, Drug - trends Neuromuscular Agents - therapeutic use Off-Label Use - ethics Off-Label Use - legislation & jurisprudence Organophosphonates - therapeutic use Policy Making Public Policy - legislation & jurisprudence Public Policy - trends Ranibizumab Tenofovir Treatment Outcome Truth Disclosure United Kingdom United States United States Food and Drug Administration |
| title | Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T02%3A25%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20I%20tell%20you%20the%20truth?%20A%20comparative%20perspective%20on%20regulating%20off-label%20scientific%20and%20medical%20information&rft.jtitle=Yale%20journal%20of%20health%20policy,%20law,%20and%20ethics&rft.au=Osborn,%20John%20E&rft.date=2010&rft.volume=10&rft.issue=2&rft.spage=299&rft.epage=356&rft.pages=299-356&rft.issn=1535-3532&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E748995710%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748995710&rft_id=info:pmid/20681438&rfr_iscdi=true |